Anduril IPO: Date, Valuation and What Investors Need to Know

An Anduril IPO would be the most anticipated defence listing in decades. The nine-year-old defence technology company, founded by Oculus creator Palmer Luckey, doubled its valuation to $61 billion in May 2026, doubled revenue to $2.2 billion in 2025, and was reported in July 2026 to be in talks to raise new funding at a $100 billion valuation. Its founder has said, on the record, that a public listing is a certainty — the only open questions are when, and at what price.

This guide gathers everything traders and investors need in one place: the company behind the hype, the latest signals on timing, the valuation trail, who owns it, the risks, and — since Anduril shares remain out of reach for retail investors today — how to build exposure to the defence tech theme now and be ready on listing day.

Anduril IPO at a glance (September 2026):

• Status: Private. No S-1 filed, no exchange or underwriters named.
• Latest valuation: $61 billion (May 2026 Series H); reported talks at ~$100 billion (July 2026).
• Revenue: $2.2 billion in 2025, roughly doubling year on year.
• Expected window: Analysts and secondary-market platforms point to 2026–2027.

What is Anduril Industries?

Anduril Industries is an American defence technology company founded in 2017 in Costa Mesa, California. Its pitch from day one: the Pentagon's biggest problem is not a lack of money but a lack of Silicon Valley-grade software and speed, and the solution is a company that builds autonomous, AI-driven defence products the way a tech startup builds consumer hardware — fast, iteratively, and with its own capital.

That pitch was easy to dismiss in 2017. It is much harder to dismiss now that Anduril supplies the US military and allied forces across air, land, sea, and space, and won a US Army enterprise agreement in March 2026 with a ceiling of up to $20 billion over ten years.

Anduril's products and platforms

Anduril's product family spans software and an expanding fleet of autonomous hardware:

• Lattice — the core AI command-and-control platform that fuses data from thousands of sensors and orchestrates fleets of autonomous systems. Every other Anduril product plugs into it.
• Fury — an autonomous combat jet developed for the US Air Force's Collaborative Combat Aircraft (CCA) programme. Production began in March 2026 at Anduril's new Arsenal-1 factory in Ohio, with capacity for up to 150 aircraft a year at full shift load (Breaking Defense).
• Roadrunner — a reusable, vertical take-off interceptor for downing drones and missiles.
• Barracuda — a family of low-cost, mass-producible cruise missiles.
• Ghost and Dive-LD / Ghost Shark — autonomous helicopter and undersea vehicles, the latter developed with the Australian Navy.
• EagleEye — a mixed-reality soldier headset programme built in partnership with Meta, after Anduril took over the US Army's troubled IVAS headset effort from Microsoft.

The thread connecting all of it is Arsenal-1, the company's one-million-square-foot Ohio plant designed to mass-produce Fury, Roadrunner, Barracuda, and a classified platform by the end of 2026 — Anduril's bid to prove that a software company can also be a wartime-scale manufacturer.

How Anduril's business model differs from traditional defence contractors

Traditional prime contractors mostly operate on cost-plus contracts: the government defines a requirement, funds the development for years, and pays the contractor's costs plus a fixed margin. It is safe, slow, and offers little incentive for efficiency.

Anduril inverted the model. It develops products with its own venture capital first, then sells finished, working systems to governments at a fixed price — the way Apple sells iPhones rather than the way Lockheed builds fighters. The company bears the development risk; in exchange, it keeps the upside on margins and speed, and it can sell the same product to many customers. That is precisely why Anduril has needed to raise so much private capital, and why its eventual access to public markets matters strategically, not just financially.

Is Anduril going public?

Yes — by the founder's own account, it is a matter of when, not if. Speaking to CNBC in June 2025, Palmer Luckey put it flatly:

"We are definitely going to be a publicly traded company." — Palmer Luckey, Anduril founder, CNBC, June 2025

Source: https://www.cnbc.com/2025/06/10/anduril-palmer-luckey-ipo.html

Luckey's reasoning is strategic: he has argued there is not "really a path" for a company like Anduril to win the largest defence programmes — the trillion-dollar class of national commitments — while remaining private, because governments need the transparency, permanence, and capital depth of a public company in their biggest suppliers.

What has not happened yet matters just as much: as of September 2026, Anduril has filed no S-1 registration statement, named no underwriters, and set no date. Everything beyond Luckey's stated intent is inference.

Anduril IPO date: when could it list?

No official date exists, but the signals cluster around a 2026–2027 window:

• In October 2025, Luckey said Anduril would go public "in the next few years" (Orange County Business Journal).
• He has tied the timing to proving that Arsenal-1 can deliver at scale — a milestone the company says it will hit as Fury, Roadrunner, and Barracuda lines all come online through late 2026.
• Secondary-market platform Forge Global has put the probability of a 2026 listing at roughly 60% (Forge).
• The reported July 2026 talks to raise privately at a ~$100 billion valuation (TechCrunch) cut both ways: enormous private demand reduces the need to list soon, but a round of that size is also exactly how companies set a reference price ahead of an IPO.

A realistic reading: late 2026 at the earliest, 2027 more likely if the company takes the mega-round instead. Traders should treat any specific date circulating online as speculation until an S-1 appears.

Anduril valuation: how much is the company worth?

Anduril's last confirmed price tag is $61 billion, set in May 2026 when it raised $5 billion in a Series H round led by Thrive Capital and Andreessen Horowitz — double its valuation of a year earlier (CNBC). Two months later, TechCrunch reported the company was in talks to raise again at approximately $100 billion.

For context, $61 billion already places Anduril above the market capitalisation of several long-established public primes, on a fraction of their revenue. The valuation is a bet that Anduril's growth rate, software margins, and product-based model deserve tech multiples rather than defence multiples — the same debate that surrounds Palantir's stock on public markets.

Anduril funding rounds and investors

The valuation trail tells the growth story on its own:

Backers include Founders Fund (whose $1 billion cheque into the Series G was the largest in the firm's history), Andreessen Horowitz, Thrive Capital, General Catalyst, Valor Equity Partners, 8VC, and Lux Capital (Sacra, Clay). Total raised exceeds $11 billion — extraordinary for a private company, and a hint of how large the eventual float could be.

Anduril revenue and profitability

Anduril's revenue has roughly doubled every year: about $1 billion in 2024, then $2.2 billion in 2025, a figure disclosed by CEO Brian Schimpf when announcing the Series H (TechCrunch).

The company is not profitable. It is reported to be projecting an operating loss of around $1.2 billion for 2026, driven by heavy upfront spending on R&D and the Arsenal-1 build-out ahead of revenue from large multi-year contracts. That is the products-not-programmes model working as designed — spend your own money first, harvest later — but it means IPO investors will be buying a growth story, not current earnings. The $20 billion-ceiling Army agreement and the Air Force CCA programme are the clearest signposts for where that later harvest could come from.

Who owns and runs Anduril?

Anduril was founded by five people, four of whom remain the public faces of the company:

• Palmer Luckey — founder and the company's public voice. Sold Oculus to Facebook for $2 billion at 21, founded Anduril at 24. Remains a major shareholder.
• Brian Schimpf — co-founder and CEO, the operational and engineering lead.
• Trae Stephens — co-founder and chairman, also a partner at Founders Fund.
• Matt Grimm — co-founder and COO.

The rest of the cap table is dominated by the venture firms above, with Founders Fund the most deeply committed. Exact ownership percentages are private and will only become public in an S-1 — one of many reasons that filing will be closely read.

Anduril's competitors in defence and defence tech

Anduril fights on two fronts:

• Traditional primes — Lockheed Martin, RTX, Northrop Grumman, Boeing, General Dynamics, and General Atomics, whose rival YFQ-42A competes directly against Anduril's Fury in the Air Force CCA programme. These companies have decades-long relationships, enormous installed bases, and political weight — but legacy cost structures.
• Defence tech challengers — Palantir (the closest public comparable, in AI software), Shield AI (autonomy), Skydio (drones), Saronic (autonomous vessels), Castelion (missiles), Epirus (directed energy), and Europe's Helsing. SpaceX, though not a weapons maker, proved the venture-funded model Anduril runs on — and its own long-awaited public listing shapes expectations for how a defence tech mega-IPO might trade.

An Anduril listing would instantly create the purest public play on autonomous defence — which is exactly why the whole sector watches its timing.

Can you buy Anduril shares before the IPO?

For ordinary retail investors: no. Anduril is private, and its shares do not trade on any exchange. The realistic answer for most readers is that exposure has to come indirectly — through public defence and defence tech stocks — until listing day.

Pre-IPO secondary markets and share transfer restrictions

A limited private market does exist. Platforms such as Forge Global, EquityZen, and Hiive match sellers — usually early employees — with buyers. But the barriers are substantial:

• Accreditation requirements. These marketplaces serve accredited/professional investors, with minimum tickets that commonly run into tens of thousands of dollars.
• Company transfer restrictions. Anduril, like most sought-after private companies, retains rights of first refusal and approval over transfers; many attempted sales simply never complete.
• Thin, stale pricing. Secondary quotes can run far above or below the last funding round, with wide spreads and none of the disclosure a public company must provide.
• No liquidity. Once bought, pre-IPO shares can rarely be resold quickly, and a listing can still be years away.

For most traders, the cost, opacity, and lock-up risk outweigh the head start. The disciplined alternative is to prepare for the listing itself — covered below.

What to look for in an Anduril IPO filing

When the S-1 lands, it will replace years of leaks with audited fact. The sections worth reading first:

• Revenue quality — how much of the $2.2 billion+ is recurring or contracted backlog versus one-off deliveries, and how concentrated it is in a handful of US government programmes.
• The loss trajectory — whether operating losses are narrowing as Arsenal-1 scales, and how much of the spend is one-time factory build-out versus permanent cost.
• Contract ceilings versus actual orders — a "$20 billion ceiling" is not $20 billion of revenue; the filing will show real task orders.
• Share structure — whether founders hold super-voting shares, and how much control Luckey and Founders Fund retain.
• Lock-up terms — when the flood of insider shares (from over $11 billion of private capital) can hit the market.
• Use of proceeds — more factories, acquisitions, or simply liquidity for early holders.

Key risks around an Anduril IPO

• Timing risk. No S-1 exists. The listing could slip to 2027 or beyond, especially if private mega-rounds keep the company funded.
• Valuation risk. The price doubled in a year and reported talks imply another near-doubling. A listing priced for perfection leaves little room for disappointment — and early public trading in richly valued IPOs is historically volatile in both directions.
• Losses and execution. A projected ~$1.2 billion operating loss depends on Arsenal-1 scaling on schedule; manufacturing is precisely where software companies historically stumble.
• Customer concentration and politics. Revenue depends overwhelmingly on the US government and allies. Budget fights, programme cancellations, or a shift in administration priorities can reprice the story overnight.
• Competition. The CCA programme is a head-to-head contest; losing a marquee competition to General Atomics or a prime would dent the narrative that underpins the multiple.
• Sentiment risk. Defence tech valuations ride geopolitical fear. De-escalation is good for the world and hard on the sector's multiples.

How to get exposure to defence technology while Anduril is private

You cannot trade Anduril yet — but you can trade the theme it leads, today:

• Public defence tech: Palantir is the market's favourite Anduril proxy — AI software, government customers, tech-style multiple.
• Traditional primes: Lockheed Martin, RTX, Northrop Grumman, BAE Systems, and Europe's Rheinmetall give direct exposure to rising global defence budgets.
• Indices: US benchmarks carry meaningful aerospace and defence weight, offering diversified exposure without single-stock risk.

With a Markets.com account you can trade share CFDs on these defence names and major indices — long or short, which matters in a sector where geopolitical headlines cut both ways. If you are new to CFDs, start with our guides to leverage and margin and spreads, then rehearse the strategy on a free demo account before committing capital.

What an Anduril listing could mean for the defence sector

An Anduril IPO would be a repricing event far beyond one ticker. It would hand public markets their first pure-play autonomous defence company, forcing a live answer to the sector's core question: do software-defined defence firms deserve Palantir-style multiples or Lockheed-style ones? A strong debut would validate the venture-defence model, likely lift valuations across Shield AI, Saronic, Helsing and the rest of the private cohort, and pressure traditional primes to spin out or showcase their own autonomy businesses. A weak one would chill the entire defence tech funding boom that Anduril itself ignited. Either way, expect volatility to spill into Palantir and the primes around filing, pricing, and the first earnings report.

How to prepare for an Anduril IPO as a trader

• Build the watchlist now. Palantir, the major primes, and defence-heavy indices will all move around Anduril's milestones — filing, pricing, first trade.
• Track the real triggers. An S-1 filing, underwriter announcements, or a completed $100 billion round are signals; anonymous "date leaks" are not.
• Learn how IPO trading works before the day. New listings often open far from their offer price, spread wide, and swing hard in the first sessions. Decide in advance whether you trade the open, wait for the dust to settle, or trade correlated names instead.
• Plan position sizing and stops first. IPO-day volatility punishes improvised risk management more than any other setting.
• Rehearse on a demo. Practise trading a fast-moving share CFD — a Palantir earnings day is a good dress rehearsal — on a Markets.com demo account, so listing day is execution, not experiment. When Anduril lists, share CFDs make it tradable from early on, long or short, without waiting for options markets to mature.

How to Trade Stock CFDs on Markets.com: A Step-by-Step Guide

A stock CFD allows you to speculate on a company’s share-price movements without owning the underlying shares. You can open a long position if you expect the price to rise or a short position if you expect it to fall, where available.

You are trading a contract whose value tracks the underlying share price. Stock CFDs do not provide voting rights or direct ownership in the company. Before trading, confirm that the relevant stock CFD is available under the Markets.com entity serving your jurisdiction and review its live contract details.

Step 1: Open an Account

Create a Markets.com account and provide the requested registration information. Account and product availability depend on your country of residence and the Markets.com legal entity authorised to serve you.

Step 2: Verify Your Identity

Complete the KYC process by providing your personal details and answering questions about your trading experience, financial circumstances and understanding of leveraged products.

Step 3: Fund Your Account

Once your account is approved, open the funding section and review the payment methods available to you. Supported methods, processing times, account currencies and potential conversion costs may differ by jurisdiction.

Deposit only an amount consistent with your financial circumstances and risk tolerance. Meeting the minimum margin requirement does not necessarily mean that the position size is appropriate.

Step 4: Find a Stock CFD and Place the Trade

Search for the company name and confirm that you have selected the correct CFD instrument. Check its trading hours, spread, margin requirement, overnight financing charges and current availability before opening a position.

Set your position size and select Buy to open a long position or Sell to open a short position. Review the total market exposure, required margin and potential trading costs before confirming the order.

Step 5: Manage Your Risk

Consider placing a stop-loss at a level that invalidates your trading idea rather than selecting one based only on the margin available. A take-profit order can define the intended exit if the market moves in your favour.

Calculate the position size based on the distance to the stop-loss and the maximum cash loss you are prepared to accept. Monitor company earnings, revenue guidance, analyst updates, sector developments, interest rates and broader market sentiment.

Stop-loss orders may be affected by slippage. If a stock gaps following an earnings announcement or other major event, the position may close at the next available price rather than the selected stop level.

New to Markets.com? Claim a generous deposit bonus on your first trade. Hurry—this offer is only available for a limited time.

Final words on Anduril IPO

The Anduril IPO is coming — its founder has said so plainly — but as of September 2026 it remains a story of signals, not filings: a $61 billion valuation heading toward a reported $100 billion, revenue doubling annually to $2.2 billion, a factory scaling toward proof, and a 2026–2027 listing window that analysts handicap rather than know. For traders, the edge is preparation, not prediction. Build the defence tech watchlist, understand how the sector trades around geopolitics, learn the mechanics of IPO-day volatility, and have an account ready — so that when the S-1 finally drops, you are analysing it rather than scrambling. Open a Markets.com demo account today and turn the wait into rehearsal.

Anduril IPO FAQs

When is the Anduril IPO?

No date has been set. Anduril has not filed an S-1 or named underwriters. Founder Palmer Luckey has said the company will "definitely" go public and has pointed to "the next few years," with analysts and secondary platforms centring on a 2026–2027 window.

What is Anduril's valuation?

$61 billion as of its May 2026 Series H round, which raised $5 billion led by Thrive Capital and Andreessen Horowitz. In July 2026, TechCrunch reported talks to raise again at roughly $100 billion.

Can I buy Anduril stock now?

Not on any exchange. Limited pre-IPO shares trade on accredited-investor platforms such as Forge Global and EquityZen, subject to company transfer restrictions, high minimums, and thin pricing. Most investors get exposure through public defence names instead.

Is Anduril profitable?

No. Revenue reached $2.2 billion in 2025, roughly doubling year on year, but the company is reported to be projecting an operating loss of about $1.2 billion in 2026 as it funds R&D and its Arsenal-1 factory ahead of large multi-year contracts.

What ticker will Anduril trade under?

Unknown — no exchange or ticker has been announced. Any ticker circulating before an official filing is speculation.

How can I trade an Anduril listing?

Once Anduril lists, its shares become available to trade — including via share CFDs on platforms like Markets.com, which allow long and short positions. Until then, traders use proxies such as Palantir, the defence primes, and index CFDs to trade the defence tech theme.

Sources

CNBC, Anduril CEO Palmer Luckey says the defense tech company will 'definitely' go public — https://www.cnbc.com/2025/06/10/anduril-palmer-luckey-ipo.html

Orange County Business Journal, Luckey: Anduril IPO in next few years — https://www.ocbj.com/defense-2/luckey-anduril-ipo-in-next-few-years/

CNBC, Anduril doubles valuation to over $60 billion — https://www.cnbc.com/2026/05/13/anduril-valuation-defense-tech-funding-boom.html

TechCrunch, Anduril raises $5B, doubles valuation to $61B — https://techcrunch.com/2026/05/13/anduril-raises-5b-doubles-valuation-to-61b/

TechCrunch, Anduril reportedly in talks to raise at $100B valuation — https://techcrunch.com/2026/07/24/anduril-reportedly-in-talks-to-raise-funding-at-100b-valuation-more-than-3x-last-years-mark/

Breaking Defense, As Fury production starts, Anduril pledges a different approach at Arsenal-1 — https://breakingdefense.com/2026/03/as-fury-production-starts-anduril-pledging-a-different-production-approach-at-arsenal-1/

Forge Global, Anduril IPO timeline and financing details — https://forgeglobal.com/anduril_ipo/

Sacra, Anduril revenue, valuation & funding — https://sacra.com/c/anduril/